Nexstim

Navigated transcranial magnetic stimulation (nTMS): the NBS System 6 uses 3D head navigation and E-field modelling to target stimulation to a specific cortical area. FDA-cleared and CE-marked for pre-surgical mapping of the speech and motor cortex (diagnostics) and for treating depression, chronic neuropathic pain and post-stroke motor rehabilitation (therapy). Founded 2000 out of Helsinki brain-imaging research (BioMag / TKK); global distribution partnership with Brainlab.

The row

Sector

Medtech & Digital Health

Stage

In market — Product is being sold

Location

Helsinki

Founded

2000

Research origin

Aalto (BioMag)

Business ID

1628881-1 · Finnish trade register

Funding

Revenue €8M (2025)

Links

Where this sits on the map

Nexstim is one of 33 companies in Medtech & Digital Health. The others:

How this row was decided

Every row on this map is checked by hand against the trade register and the company's own material, and placed in the sector that best describes its business or its technology. Service firms and consultancies are left out, however advanced the technology they work with — the test is where the revenue comes from. Only funding figures the company or its investor has published are shown. The full rules are on the landscape ↗